Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nawroth

Showing results (21-30 of 509) with videos related to

Pageof 51
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 27, 2010
Mechanisms of diabetic nephropathy--old buddies and newcomers part 1P P Nawroth, B Isermann
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 28, 2018
Diabetic Pulmopathy: A New Clinical Challenge for DiabetologyStefan Kopf, Peter P Nawroth
Contributions to Microbiology|January 18, 2003
Modulation of the vascular endothelium during infection--the role of NF-kappa B activationAngelika Bierhaus, Peter P Nawroth
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 10, 2012
Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathyA Bierhaus, P P Nawroth
Biochemical Society Transactions|March 21, 2014
Reactive metabolites as a cause of late diabetic complicationsThomas Fleming, Peter P Nawroth
Hamostaseologie|February 16, 2005
[Coagulation, inflammation and immune response -- an evolutionary conserved plan as cause for disseminated intravasal coagulation?]A Bierhaus, P P Nawroth
Thrombosis and Haemostasis|September 8, 2004
Antiangiogenic properties of low molecular weight heparin - does tissue factor provide the answer?Angelika Bierhaus, Peter P Nawroth
Intensive Care Medicine|January 7, 1999
Nuclear factor kappaB--a new therapeutic approach?H Böhrer, P P Nawroth
Lancet (London, England)|May 29, 1999
Thrombomodulin and coronary heart diseaseP P Nawroth, H U Häring
Onkologie|August 1, 1987
Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic propertiesP P Nawroth, D M Stern
Pageof 51

Showing results (21-30 of 509) with videos related to

Sort By:
Pageof 51
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 27, 2010
Mechanisms of diabetic nephropathy--old buddies and newcomers part 1P P Nawroth, B Isermann
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 28, 2018
Diabetic Pulmopathy: A New Clinical Challenge for DiabetologyStefan Kopf, Peter P Nawroth
Contributions to Microbiology|January 18, 2003
Modulation of the vascular endothelium during infection--the role of NF-kappa B activationAngelika Bierhaus, Peter P Nawroth
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 10, 2012
Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathyA Bierhaus, P P Nawroth
Biochemical Society Transactions|March 21, 2014
Reactive metabolites as a cause of late diabetic complicationsThomas Fleming, Peter P Nawroth
Hamostaseologie|February 16, 2005
[Coagulation, inflammation and immune response -- an evolutionary conserved plan as cause for disseminated intravasal coagulation?]A Bierhaus, P P Nawroth
Thrombosis and Haemostasis|September 8, 2004
Antiangiogenic properties of low molecular weight heparin - does tissue factor provide the answer?Angelika Bierhaus, Peter P Nawroth
Intensive Care Medicine|January 7, 1999
Nuclear factor kappaB--a new therapeutic approach?H Böhrer, P P Nawroth
Lancet (London, England)|May 29, 1999
Thrombomodulin and coronary heart diseaseP P Nawroth, H U Häring
Onkologie|August 1, 1987
Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic propertiesP P Nawroth, D M Stern
Pageof 51